Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases

. 1979 Jul;40(1):156–160. doi: 10.1038/bjc.1979.152

Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.

PMCID: PMC2009950 PMID: 454560

These references are in PubMed. This may not be the complete list of references from this article.

Carnegie P. R., Caspary E. A., Field E. J. Isolation of an "antigen" from malignant tumours. Br J Cancer Suppl. 1973 Aug;1:219–223. [PMC free article] [PubMed] [Google Scholar]
Cercek L., Cercek B. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review. Eur J Cancer. 1977 Sep;13(9):903–915. doi: 10.1016/0014-2964(77)90166-9. [DOI] [PubMed] [Google Scholar]
Cercek L., Cercek B. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells. Br J Cancer. 1976 May;33(5):539–543. doi: 10.1038/bjc.1976.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cercek L., Cercek B., Franklin C. I. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders. Br J Cancer. 1974 May;29(5):345–352. doi: 10.1038/bjc.1974.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
Harris R., Ukaejiofo E. O. Rapid preparation of lymphocytes for tissue-typing. Lancet. 1969 Aug 9;2(7615):327–327. doi: 10.1016/s0140-6736(69)90096-8. [DOI] [PubMed] [Google Scholar]
Takaku F., Yamanaka T., Hashimoto Y. Usefulness of the SCM test in the diagnosis of gastric cancer. Br J Cancer. 1977 Dec;36(6):810–813. doi: 10.1038/bjc.1977.266. [DOI] [PMC free article] [PubMed] [Google Scholar]